Cyclooxygenase inhibitors are well known for their anti-inflammatory effects,
but recent data indicate that they are also potent anti-angiogenics. The mechanisms
by which nonsteroidal anti-inflammatory drugs affect cyclooxygenase enzymes,
peptic ulcers, angiogenesis and cancer are complex, but are worth sorting
out (pages 1418−1423).
